Hyperparathyroidism secondary: Which Medications Cause It? (2,198 Reports Across 79 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Hyperparathyroidism secondary has been reported as an adverse event with 79 different drugs in the FDA's FAERS database, with 2,198 total reports. 290 of these reports resulted in death.The drugs most commonly associated with Hyperparathyroidism secondary are ESOMEPRAZOLE, OMEPRAZOLE, and PANTOPRAZOLE.
2,198
Total Reports
79
Drugs Involved
290
Deaths
806
Hospitalizations
57.5 yrs
Average Patient Age
55.6% / 44.4%
Female / Male
Which Drugs Cause Hyperparathyroidism secondary Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| ESOMEPRAZOLE | 1,357 | 1.8% | 196 | 386 | 8 |
| OMEPRAZOLE | 1,274 | 1.5% | 196 | 372 | 7 |
| PANTOPRAZOLE | 947 | 1.2% | 148 | 294 | 6 |
| LANSOPRAZOLE | 888 | 1.5% | 141 | 234 | 1 |
| DEXLANSOPRAZOLE | 382 | 1.6% | 56 | 88 | 1 |
| RABEPRAZOLE | 108 | 1.0% | 22 | 30 | 0 |
| DENOSUMAB | 60 | 0.0% | 3 | 32 | 9 |
| FUROSEMIDE | 49 | 0.1% | 0 | 38 | 1 |
| OMEPRAZOLE\SODIUM BICARBONATE | 48 | 2.5% | 8 | 15 | 0 |
| ESOMEPRAZOLE\NAPROXEN | 47 | 0.8% | 16 | 10 | 0 |
| SODIUM, DIBASIC\SODIUM, MONOBASIC | 45 | 12.9% | 1 | 24 | 0 |
| TACROLIMUS | 44 | 0.1% | 0 | 40 | 0 |
| TENOFOVIR DISOPROXIL | 36 | 0.1% | 4 | 23 | 0 |
| CINACALCET | 34 | 0.1% | 3 | 18 | 0 |
| DARBEPOETIN ALFA | 34 | 0.1% | 1 | 30 | 1 |
| EMTRICITABINE\TENOFOVIR DISOPROXIL | 33 | 0.1% | 1 | 16 | 0 |
| MYCOPHENOLATE | 29 | 0.4% | 0 | 28 | 0 |
| ZOLEDRONIC ACID | 29 | 0.1% | 0 | 15 | 3 |
| CHOLECALCIFEROL | 28 | 0.2% | 0 | 27 | 0 |
| TORSEMIDE | 28 | 0.3% | 0 | 28 | 0 |